Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial.

Nikolai Kragøe Andresen Andreas Hagen RøssevoldClaire QuaghebeurBjørnar GiljeBeate BogeAndrea GombosRagnhild Sørum FalkRandi R MathiesenLars JulsrudØystein GarredHege G RussnesRagnhild Reehorst LereimSudhir Kumar ChauhanOle Christian LingjærdeClaire DunnBjørn NaumeJon Amund Kyte

Published in: Journal for immunotherapy of cancer (2024)

ClinicalTrials.gov Identifier: NCT03409198.

Keyphrases

positive breast cancer
squamous cell carcinoma
phase iii
study protocol
small cell lung cancer
locally advanced
phase ii
clinical trial
randomized controlled trial
open label
chemotherapy induced
double blind
placebo controlled